Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications

Area of Science:

• Cardiovascular biology
• Epigenetics
• Pharmacology

Background:

• Cardiovascular diseases (CVDs) are a major global health burden.
• Histone deacetylases (HDACs) are key epigenetic regulators influencing gene expression.
• HDACs are implicated in cardiac stress responses and pathological conditions.

Purpose of the Study:

• To review the role of HDACs in cardiac development and hypertrophy.
• To explore the therapeutic potential of HDAC inhibitors in heart disease.
• To discuss the molecular mechanisms underlying HDAC function in the heart.

Main Methods:

• Literature review of cellular and molecular studies on HDACs in the heart.
• Analysis of the co-regulatory networks involving HDACs.
• Examination of pharmacologic interventions targeting HDACs for cardiac dysfunction.

Main Results:

• HDACs modulate gene expression critical for cardiac development and response to stress.
• Dysregulation of HDACs contributes to cardiac hypertrophy.
• Selective HDAC inhibitors show potential for ameliorating cardiac dysfunction.

Conclusions:

• HDACs are crucial targets for managing cardiovascular diseases.
• Targeted inhibition of HDACs offers a promising therapeutic avenue for heart conditions.
• Further research into HDACs' role in cardiac pathology is warranted.